Skip to main content
Log in

Automated, serum-free production of CTX0E03: a therapeutic clinical grade human neural stem cell line

  • Original Research Paper
  • Published:
Biotechnology Letters Aims and scope Submit manuscript

Abstract

Automation of cell culture processes is necessary to achieve scalable and reproducible manufacture of cell-based therapies. CTX0E03 is a near-clinic neural stem cell line for stroke therapy. The transfer of the CTX0E03 manufacture process from a manual to a completely automated process is demonstrated by (a) adapting the manual process to conform to the automated platform and (b) conducted a large scale (20 × T175 flasks) automated CTX0E03 expansion in accordance with the working bank to drug substance lot manufacture schedule. The automated lot was within the GMP release specification for viability, growth rate, nestin immunoreactivity and transcriptome equivalence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Archer R, Williams DJ (2005) Why tissue engineering needs process engineering. Nat Biotechnol 23:1353–1355

    Article  PubMed  CAS  Google Scholar 

  • Joannides A, Fiore-Hériché C, Westmore K (2006) Automated mechanical passaging: a novel and efficient method for human embryonic stem cell expansion. Stem Cells 24:230–235

    Article  PubMed  Google Scholar 

  • Lysaught MJ, Jaklenec A, Deweerd E (2008) Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics. Tissue Eng Part A 14:305–315

    Article  Google Scholar 

  • Mansbridge J (2006) Commercial considerations in tissue engineering. J Anat 209:527–532

    Article  PubMed  CAS  Google Scholar 

  • Mason C (2007) Regenerative medicine 2.0. Regen Med 2:11–18

  • Pollock K, Stroemer P, Patel S, Stevanato L, Hope A, Miljan E, Dong Z, Hodges H, Price J, Sinden JD (2006) A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke. Exp Neurol 199:143–155

    Article  PubMed  Google Scholar 

  • Terstegge S, Laufenberg I, Pochert J (2007) Automated maintenance of embryonic stem cell cultures. Biotechnol Bioeng 96:195–201

    Article  PubMed  CAS  Google Scholar 

  • Thomas RJ, Hourd PC, Williams DJ (2008a) Application of process quality engineering techniques to improve the understanding of the in vitro processing of stem cells for therapeutic use. J Biotechnol 136:148–155

    Article  PubMed  CAS  Google Scholar 

  • Thomas RJ, Anderson D, Chandra A, Smith NM, Young LE, Williams D, Denning C (2008b) Automated, scalable culture of human embryonic stem cells in feeder-free conditions. Biotech Bioeng (early view online)

  • Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3(7):research0034.1-0034.11

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. J. Thomas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thomas, R.J., Hope, A.D., Hourd, P. et al. Automated, serum-free production of CTX0E03: a therapeutic clinical grade human neural stem cell line. Biotechnol Lett 31, 1167–1172 (2009). https://doi.org/10.1007/s10529-009-9989-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10529-009-9989-1

Keywords

Navigation